coronavirus pandemic.It’s called Nicotiana benthamiana, a relative of the tobacco plant, native to Australia, and it is a key to biopharmaceutical company Medicago’s COVID-19 vaccine.Medicago is the leading Canadian-based contender to produce a vaccine, with an agreement to provide the federal government with 76 million doses if approved for use.
Canadian company sees positive results in early coronavirus vaccine tests Medicago’s vaulting onto the mainstage could provide a breakthrough for vaccine science.